NCT00617799 2023-10-10
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
Completed
University of Nebraska
City of Hope Medical Center
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Case Comprehensive Cancer Center
Children's Oncology Group